This page follows insider dealings at Tecan Group AG as filed with SIX SER, a company from the Health Care sector based in Männedorf, Switzerland. The group dates from 1980. Its latest reported headcount is 1,869 employees (2023). Over the twelve months to 18 October 2026, 4 filings were filed, from 2 insiders.
All open-market trades in the period are sales: 4 sales worth €1.2M, by 2 insiders, with no purchase on record. One trade stands out by size: a sale of €333k, disclosed on 2 September 2026, or 0.012% of market capitalisation.
Compared with its exchange (178 companies, median 9 filings), a count of 4 filings is below the norm. Looking back to 2023, when coverage begins, insiders filed no purchases and 16 sales.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from SIX SER. Past trades are no guide to future returns.
Analysts rate Tecan Group AG Buy (bullish), based on 8 analysts. Average price target: CHF 209.35.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
16 of 16 declarations
Tecan Group AG is a company specializing in the development and manufacturing of automation solutions for laboratories. It primarily operates in the healthcare and pharmaceutical sector.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Männedorf, Switzerland · Founded: 1980 · 1,869 employees (2023) · Wikipedia article
Source: Wikidata (CC0).